Delivery Order SPE2DX22D0129-SPE2D826F0DHM
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,447.93 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 20, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting the contractor's capability to...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $261,593.56 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries a completion date of January 7, 2026, represents a task order issued against the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded with no set-aside designation, leveraging...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $47,641.79 on January 14, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, which utilized no set-aside designation, represents a task order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the company's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $124,469.46 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 14, 2026, represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will be...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,343.79 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The ultimate completion date is set for January 20, 2026, and performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $106,140 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded task against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is to be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $109,351.92 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on January 20, 2026, with performance occurring at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $57,626.94 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which has an ultimate completion date of January 13, 2026, represents work to be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement, reflecting the...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $46,035 on January 13, 2026, by the Defense Logistics Agency's Medical Supply Chain to supply pharmaceutical products and medical supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and represents work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a non-set-aside, fully...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,449.90 on January 13, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of January 14, 2026, represents a child task order under a significantly larger Indefinite Delivery Contract. The award was made on a non-set-aside, fully competitive basis and is being performed at the awardee's corporate office location in...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DHMDelivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is scheduled for ultimate completion by January 20, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's prime IDC with DLA Troop Support Medical valued at up to $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The award demonstrates AmerisourceBergen's sustained capability to fulfill federal medical supply requirements through open competition and its established position as a key provider within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 1/18/26 |